Biotech

Back to Life Sciences & Healthcare

Recent years have seen an increase in the numbers of biotech IPOs and more investment in the sector, however it can still be challenging accessing the finance necessary to fund R&D and to bring products to the market.

As part of the biotech industry you will expect your lawyers to assist you in tackling these difficult financing and market challenges. Our team of sector specialists, including lawyers with technical backgrounds, understands the commercial drivers in this industry and can advise you on the full spectrum of legal matters.

Our clients range from universities and their spin-out companies through to mature biotech multinationals.

For companies looking to fund R&D or ensure the viability of their future pipeline, you will need to undertake the kinds of collaborations that have been behind many of the most successful biotech products. Through our extensive work acting for biotech organisations, we advise on the full range of collaboration and licensing agreements at all stages of product development, including R&D collaborations and commercialisation agreements.

In addition to helping you commercialise your intellectual property, we can help protect it through our knowledge of intellectual property rights enforcement .  

With products at the forefront of biomedical knowledge, the regulatory framework applicable will often be complex. We advise on the regulatory requirements applicable to tissues/cells, biological therapies, in addition to clinical trials. We also advise on pricing, reimbursement and public procurement issues on any authorised product to help ensure its profitability, even in the face of increasing pressure on pricing.

We have extensive experience advising on fundraising for start-ups along with IPOs and capital markets fundraising for developed companies, as well as public and private M&A in the sector.

Highlights of our experience in Biotech
Roslin Biomed (the “Dolly the Sheep” company) through its lifecycle and on its acquisition by Geron Corp.hVIVO plc on PrEP Biopharm Limited’s licencing arrangements to enable PrEP to develop and...
Law-Now: Lifesciences
Visit Law-Now for legal know-how and commentary
Advising the Board

Feed

04/06/2019
Future Leaders
We are pleased to invite you to the latest seminar in our 'Future Leaders Seminar Series' which is run by less senior members of our team for the benefit of junior in-house lawyers and other pro­fes­sion­als.This...
29/11/2018
(Webinar) Vital Signs
The UK Life Sciences sector welcomed Sir John Bell’s Life Sciences Industrial Strategy last year. Its bold vision and ambition have the potential to drive a new era of growth. But as a new survey by...
19/09/2018
Future Leaders Seminar Series
We are pleased to announce the third seminar in our 'Future Leaders Seminar Series' which is run by less senior members of our team for the benefit of junior in-house lawyers and other professionals...
20/06/2018
Innovation in the Cloud - Reducing IP Risk for the Life Sciences and Healthcare...
New technologies like cloud computing are transforming the Life Sciences industry. Many businesses now incorporate data analytics and software development into their core operations. In the process, healthcare...
21/06/2017
Lifesciences Webinars: Spring Series 2017
We are delighted to invite you to the Spring Webinar Series hosted by the CMS Lifesciences Sector Group.The series has been designed to give you and your colleagues an overview of the legal aspects of...
21/06/2017
Lifesciences Webinars: Spring Series 2017
We are delighted to invite you to the Spring Webinar Series hosted by the CMS Lifesciences Sector Group.The series has been designed to give you and your colleagues an overview of the legal aspects of...
11/05/2017
Lifesciences Webinars: Spring Series 2017
We are delighted to invite you to the Spring Webinar Series hosted by the CMS Lifesciences Sector Group.The series has been designed to give you and your colleagues an overview of the legal aspects of...